Hemodialysis (HD) patients are at high risk for all‐cause mortality and cardiovascular
events. In addition to traditional risk factors, excessive oxidative stress (OS) and chronic …

Oxidative stress (OS) is the result of prooxidant molecules overwhelming the antioxidant
defense mechanisms. Hemodialysis (HD) constitutes a state of elevated inflammation and …

Recent studies indicate that cerebrovascular diseases and processes of atherosclerosis
originate in the childhood era and are largely influenced by chronic inflammation. Some …

Antioxidants have been used as therapies to decrease oxidative stress and improve CVD
risk in hemodialysis (HD) patients. A systematic search of the Medline database (search …

The disruption of balance between production of reactive oxygen species and antioxidant
systems in favor of the oxidants is termed oxidative stress (OS). To counteract the damaging …

The availability of erythropoiesis-stimulating agents (ESAs) has revolutionized the treatment
of anaemia in patients with chronic kidney disease. However, maintaining patients at …

Routine administration of erythropoietin (EPO)-stimulating agents (ESAs) for the control of
anemia has improved the quality of life of subjects with chronic kidney disease (CKD) …

End‐stage renal disease (ESRD) is characterized by a high mortality rate, derived largely
from cardiovascular disease (CVD). In patients with ESRD, high levels of pro‐inflammatory …

We have recently proposed severe cardiorenal syndrome (SCRS), in which cardiac and
renal failure mutually amplify progressive failure of both organs. This frequent …

Background. Available data about oxidative status in patients with end-stage renal disease
(ESRD) or on dialysis are contradictory. The present cross-sectional study aimed to …